BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang SS, Zhang T, Wang XL, Hong L, Qi QH. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World J Gastroenterol 2003; 9(5): 930-935 [PMID: 12717832 DOI: 10.3748/wjg.v9.i5.930] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Luo L, Qiao H, Meng F, Dong X, Zhou B, Jiang H, Kanwar JR, Krissansen GW, Sun X. Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas. Int J Cancer 2006;118:1823-30. [DOI: 10.1002/ijc.21557] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
2 Nithyananthan S, Thirunavukkarasu C. Chemotherapeutic doses of arsenic trioxide delays hepatic regeneration by oxidative stress and hepatocyte apoptosis in partial hepatectomy rat. Toxicology and Applied Pharmacology 2019;382:114760. [DOI: 10.1016/j.taap.2019.114760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
3 Alazzouni AS, Mahmoud AA, Omran MM, Essawy EA, Abdalla MS, Abdelfattah MS. Inhibitory and ameliorative effect of heliomycin derived from actinomycete on induced hepatocellular carcinoma in rats. Naunyn Schmiedebergs Arch Pharmacol 2021;394:1091-102. [PMID: 33416934 DOI: 10.1007/s00210-020-02043-5] [Reference Citation Analysis]
4 Chakraborty T, Chatterjee A, Rana A, Srivastawa S, Damodaran S, Chatterjee M. Cell proliferation and hepatocarcinogenesis in rat initiated by diethylnitrosamine and promoted by phenobarbital: Potential roles of early DNA damage and liver metallothionein expression. Life Sciences 2007;81:489-99. [DOI: 10.1016/j.lfs.2007.06.023] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
5 Nithyananthan S, Thirunavukkarasu C. Arsenic trioxide, a cancer chemo drug hampers fibrotic liver regeneration by interrupting oxidative stress rekindling and stellate cell rejuvenation. J Cell Physiol 2020;235:1222-34. [PMID: 31270803 DOI: 10.1002/jcp.29037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Hua HQ, Qin SK, Wang JH, Chen HY. Effect of arsenic trioxide on vascularization of tumor. Shijie Huaren Xiaohua Zazhi 2004; 12(1): 27-31 [DOI: 10.11569/wcjd.v12.i1.27] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Schwartz JD, Llovet JM. Molecular Targeting in Hepatocellular Carcinoma. In: Kaufman HL, Wadler S, Antman K, editors. Molecular Targeting in Oncology. Totowa: Humana Press; 2008. pp. 165-210. [DOI: 10.1007/978-1-59745-337-0_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Seong NJ, Yoon CJ, Kang SG, Chung JW, Kim HC, Park JH. Effects of arsenic trioxide on radiofrequency ablation of VX2 liver tumor: intraarterial versus intravenous administration. Korean J Radiol 2012;13:195-201. [PMID: 22438687 DOI: 10.3348/kjr.2012.13.2.195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
9 Gu XH, Zhang YD, Li QF, Wang YM. Expression of Bcl-2/Bax, Bak and hepatocytic apoptosis in tissues of patients with hepatitis D. Shijie Huaren Xiaohua Zazhi 2004; 12(7): 1578-1581 [DOI: 10.11569/wcjd.v12.i7.1578] [Reference Citation Analysis]
10 Paul MK, Kumar R, Mukhopadhyay AK. Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells. Toxicol Appl Pharmacol. 2008;226:140-152. [PMID: 18022205 DOI: 10.1016/j.taap.2007.09.020] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
11 Kim HJ, Shin JH, Kim T, Kim EY, Park YS, Park C, Song H. Efficacy of Transarterial Embolization with Arsenic Trioxide Oil Emulsion in a Rabbit VX2 Liver Tumor Model. Journal of Vascular and Interventional Radiology 2009;20:1365-70. [DOI: 10.1016/j.jvir.2009.07.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
12 Tong JL, Ran ZH, Chen X, Xiao SD. Expression of the Bcl-2 family is influenced by Epigallocatechin-3 -gallate in human gastric cancer cell MKN 45. Shijie Huaren Xiaohua Zazhi 2006; 14(30): 2913-2917 [DOI: 10.11569/wcjd.v14.i30.2913] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
13 Soriano C, Creus A, Marcos R. Arsenic trioxide mutational spectrum analysis in the mouse lymphoma assay. Mutat Res 2008;646:1-7. [PMID: 18822301 DOI: 10.1016/j.mrfmmm.2008.08.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
14 Chakraborty T, Chatterjee A, Dhachinamoorthi D, Srivastawa S, Panayappan L, Chatterjee M. Vanadium limits the expression of proliferating cell nuclear antigen and inhibits early DNA damage during diethylnitrosamine-induced hepatocellular preneoplasia in rats. Environ Mol Mutagen. 2006;47:603-615. [PMID: 16878318 DOI: 10.1002/em.20246] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gunasekaran V, Elangovan K, Niranjali Devaraj S. Targeting hepatocellular carcinoma with piperine by radical-mediated mitochondrial pathway of apoptosis: An in vitro and in vivo study. Food Chem Toxicol 2017;105:106-18. [PMID: 28341137 DOI: 10.1016/j.fct.2017.03.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
16 Wang X, Wang G, Dong D, Fu S, Yang B. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide. Experimental and Toxicologic Pathology 2008;60:481-8. [DOI: 10.1016/j.etp.2008.04.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
17 Zhang Q, Vakili MR, Li X, Lavasanifar A, Le XC. Polymeric micelles for GSH-triggered delivery of arsenic species to cancer cells. Biomaterials 2014;35:7088-100. [DOI: 10.1016/j.biomaterials.2014.04.072] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
18 Chakraborty T, Chatterjee A, Saralaya M, Dhachinamoorthi D, Chatterjee M. Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model. Life Sciences 2006;78:2839-51. [DOI: 10.1016/j.lfs.2005.11.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]